Langerhans cell histiocytosis of the urinary bladder in a patient with bladder cancer previously treated with intravesical Bacillus Calmette-Guerin therapy

被引:6
|
作者
Numakura, Satoe [1 ]
Morikawa, Teppei [1 ]
Ushiku, Tetsuo [1 ]
Toyoshima, Toyoaki [2 ]
Fukayama, Masashi [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 1130033, Japan
[2] Yuai Mem Hosp, Dept Urol, Koga, Japan
关键词
Eosinophilic granuloma; Histiocytosis X; Immunohistochemistry; Immunotherapy; Pathological diagnosis; ERDHEIM-CHESTER DISEASE; BRAF V600E MUTATION; EOSINOPHILIC CYSTITIS; MITOMYCIN-C; CARCINOMA; VEMURAFENIB; DIAGNOSIS; GRANULOMA; MELANOMA; TUMOR;
D O I
10.1016/j.prp.2013.11.005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We report an extremely rare case of Langerhans cell histiocytosis (LCH) of the urinary bladder. A 68-year-old man presented with gross hematuria. Cystoscopy showed multiple papillary tumors in the urinary bladder, and transurethral resection was performed. Pathological diagnosis was high-grade papillary urothelial carcinoma with lamina propria invasion. The patient received six treatments with intravesical Bacillus Calmette-Guerin (BCG) therapy. Seven months after surgery, follow-up cystoscopy showed three elevated lesions in the urinary bladder, two of which were identified histologically as recurrent urothelial carcinoma. Microscopic examination of the lesion at the anterior wall revealed diffuse infiltration of medium to large histiocytoid cells in the lamina propria, many of which had distorted nuclei and nuclear grooves. Dense eosinophilic infiltration was also observed. Immunohistochemically, the histiocytoid cells were diffusely positive for S-100 and CD1a, but negative for cytokeratin AE1/AE3 and melanosome-associated antigen recognized by HMB-45. Based on the histological and immunohistochemical features, we diagnosed the lesion as LCH of the urinary bladder. There was no evidence of recurrence of either bladder cancer or LCH after an 18-month follow-up. To avoid misdiagnosis, urologists and pathologists should be aware that LCH may develop in the urinary bladder after intravesical BCG therapy for bladder cancer. (C) 2013 Elsevier GmbH. All rights reserved.
引用
收藏
页码:123 / 126
页数:4
相关论文
共 50 条
  • [41] USE OF INTRAVESICAL BACILLUS CALMETTE-GUERIN IN THE TREATMENT OF SUPERFICIAL TRANSITIONAL CELL-CARCINOMA OF THE BLADDER - AN OVERVIEW
    WITJES, JA
    VANDERMEIJDEN, APM
    DEBRUYNE, FMJ
    UROLOGIA INTERNATIONALIS, 1990, 45 (03) : 129 - 136
  • [42] The Correct Sequence of Intravesical Chemotherapy and Bacillus Calmette-Guerin for Non-Muscle-invasive Bladder Cancer
    Oosterlinck, Willem
    Decaestecker, Karel
    EUROPEAN UROLOGY, 2015, 67 (03) : 517 - 518
  • [43] Intravesical bacillus Calmette-Guerin treatment improves patient survival in T1G3 bladder tumours
    Patard, JJ
    Rodriguez, A
    Leray, E
    Rioux-Leclercq, N
    Guillé, F
    Lobel, B
    EUROPEAN UROLOGY, 2002, 41 (06) : 635 - 641
  • [44] Intravesical bacillus Calmette-Guerin combined with electromotive mitomycin for high-risk superficial bladder cancer
    Bochner, Bernard H.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (09): : 474 - 475
  • [45] Bacillus Calmette-Guerin strain differences as the basis for immunotherapies against bladder cancer
    Miyazaki, Jun
    Onozawa, Mizuki
    Takaoka, Eiichiro
    Yano, Ikuya
    INTERNATIONAL JOURNAL OF UROLOGY, 2018, 25 (05) : 405 - 413
  • [46] Recombinant bacillus Calmette-Guerin in urothelial bladder cancer immunotherapy: current strategies
    Wang, Yonghua
    Yang, Meng
    Yu, Qinchao
    Yu, Lun
    Shao, Shixiu
    Wang, Xinsheng
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (01) : 85 - 93
  • [47] Small bladder and multiple urethral recurrences after intravesical instillation of bacillus Calmette-Guerin for superficial transitional cell carcinoma of the bladder
    Manasia, P
    Alcaraz, A
    Cetina, A
    Alcover, J
    JOURNAL OF UROLOGY, 2001, 165 (02) : 529 - 530
  • [48] INTRACAVITARY BACILLUS CALMETTE-GUERIN IN THE TREATMENT OF SUPERFICIAL BLADDER TUMORS
    Morales, A.
    Eidinger, D.
    Bruce, A. W.
    JOURNAL OF UROLOGY, 2017, 197 (02) : S142 - S144
  • [49] Clinical practice of UroVysion® urine test in patients with bladder carcinoma in situ treated with intravesical Bacillus Calmette-Guerin
    Miyake, Makito
    Hori, Shunta
    Fujii, Tomomi
    Nishimura, Nobutaka
    Oda, Yuki
    Miyamoto, Tatsuki
    Tomizawa, Mitsuru
    Shimizu, Takuto
    Ohnishi, Kenta
    Morizawa, Yosuke
    Gotoh, Daisuke
    Nakai, Yasushi
    Torimoto, Kazumasa
    Tanaka, Nobumichi
    Fujimoto, Kiyohide
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2023, 53 (07) : 629 - 632
  • [50] CLINICAL-EVIDENCE OF SYSTEMIC PERSISTENCE OF BACILLUS CALMETTE-GUERIN - LONG-TERM PULMONARY BACILLUS CALMETTE-GUERIN INFECTION AFTER INTRAVESICAL THERAPY FOR BLADDER-CANCER AND SUBSEQUENT CYSTECTOMY
    BOHLE, A
    KIRSTEN, D
    SCHRODER, KH
    KNIPPER, A
    FORNARA, P
    MAGNUSSEN, H
    JOCHAM, D
    JOURNAL OF UROLOGY, 1992, 148 (06) : 1894 - 1897